TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
ENOV

Enovis Corp

Healthcare · Medical Devices

17.70$ +1.5% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

Enovis Corp (ENOV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 583 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ENOV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
879 934 845 966 845 874 881 925 875 985 1,008 909 847 888 816 620 806 828 879 356 360 1,023 375 395 384 409 406 429 418 455 516 525 505 561 559 565 549 576 589 583 2,297
604 645 566 665 581 606 610 638 604 681 649 533 478 493 468 379 462 473 508 156 162 605 170 179 168 177 171 180 175 191 218 236 219 253 227 230 262 226 266 224 978
275 289 279 301 264 268 271 287 271 304 358 376 368 396 348 241 344 355 371 201 198 419 206 216 216 232 235 248 243 264 298 289 286 308 332 335 287 349 324 359 1,319
– 39 – – – – – – – 34 – – 16 17 19 14 17 19 20 11 12 27 15 16 16 15 18 19 20 18 23 23 20 24 29 31 30 31 32 32 124
– – – – – – – – – – – – – – – – – – 306 338 334 352 369 225 182 209 207 208 204 211 256 264 250 258 269 267 264 270 283 264 1,081
200 198 206 208 182 199 201 205 195 218 318 308 291 304 301 246 282 296 310 211 214 363 237 210 234 260 260 263 263 270 333 333 318 972 375 351 278 301 303 342 1,224
51 66 66 92 75 -176 62 66 60 49 25 42 68 92 47 -4.9 62 58 61 -10 -16 55 -31 5.6 -18 -28 -25 -14 -20 -5.8 -35 -44 -32 -665 -43 -16 9.0 48 20 17 95
6.9 5.4 9.3 8.5 11 12 9.6 13 12 15 29 33 32 33 25 28 26 26 26 18 14 16 15 4.5 6.3 6.1 5.7 4.1 5.8 4.3 20 17 11 9.1 9.2 9.3 21 7.5 19 8.0 56
44 61 57 84 63 -188 38 61 50 34 -48 8.4 2.4 59 22 -33 36 33 36 -46 -20 40 -38 116 -78 -2.5 -30 -19 -26 7.7 -79 -27 -43 -674 -57 -26 -567 -510 0.6 7.5 -1,068
12 18 16 25 14 -3.6 6.0 -6.9 12 -12 -3.6 6.2 -1.4 25 13 -30 20 -8.7 7.9 -3.8 -6.7 28 0.4 -4.2 -12 52 -7.1 -4.7 -6.1 4.6 -7.4 -8.9 -9.1 30 -1.8 11 4.0 9.3 9.0 8.5 31
28 38 39 53 46 13 25 38 31 46 -52 -469 10 -17 4.5 -8.5 13 33 19 29 26 -1.9 15 77 -67 -39 -23 -10.0 -2.9 3.0 -72 -19 -32 -703 -56 -37 -571 -521 -8.8 -1.2 -1,102
92 102 92 107 115 -146 84 91 74 82 47 146 152 137 105 57 123 124 124 26 62 121 43 172 -22 56 28 38 36 69 14 55 40 -590 23 55 -472 -425 93 87 -717

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?